D. Gnonlonfoun, M. Agbétou, A. Wanvoegbe, C. Adjien, R. Gnimavo, A. Sowanou, R. Domingo, Joseph Adoco, D. Zannou, D. Houinato
{"title":"在撒哈拉以南非洲的医院环境中,贝宁病例中hiv感染患者的原发性头痛疾病:患病率和相关因素","authors":"D. Gnonlonfoun, M. Agbétou, A. Wanvoegbe, C. Adjien, R. Gnimavo, A. Sowanou, R. Domingo, Joseph Adoco, D. Zannou, D. Houinato","doi":"10.4236/wjns.2019.94021","DOIUrl":null,"url":null,"abstract":"Introduction: Headache disorders are common in HIV-infected patients. These disorders are either primary or secondary. Objective: Determine prevalence and factors associated with primary headache disorders in HIV+ patients. Method: It was a cross-sectional, descriptive and analytical study conducted from 2nd May 2017 to 2nd August 2017 which included HIV+ patients aged 18 years and above. Diagnosis of primary headache disorders was carried out by a Neurologist on the basis of ICHD-II diagnostic criteria. The dependent variable was primary headache disorders. Epi Info Version 7.2.1.0 and STATA11 were used for data analysis. P Results: Primary headache disorders prevalence was 25.2% (124/493).Tension-type headache represented 77.41%. HIV+ patients were aged 42.63 ± 10.14 years. Sex-ratio was estimated at 0.14. Factors associated with primary headache disorders in HIV+ patients were: male (0.36 [0.17 - 0.77]; P = 0.008), Dendi ethnicity (14.8 [2.08 - 101.99]; P = 0.007), trader (3.09 [01.25 - 7.62]; P = 0.02), WHO clinical stage (3.20 [1.43 - 7.17]; P = 0.005), screening duration (1.01 [1.00 - 1.01]; P = 0.00), hypertension (10.28 [4.44 - 23.83]; P ≤ 0.001). Conclusion: This study helped to determine the standard profile of HIV+ patient with primary headache disorders. It will contribute to save costs associated with paraclinical examinations, while in search of secondary etiologies within an African context with limited financial resources.","PeriodicalId":23878,"journal":{"name":"World Journal of Neuroscience","volume":"8 3 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Primary Headache Disorders in HIV-Infected Patients within a Hospital Setting in Sub-Saharan Africa, Benin Case: Prevalence and Associated Factors\",\"authors\":\"D. Gnonlonfoun, M. Agbétou, A. Wanvoegbe, C. Adjien, R. Gnimavo, A. Sowanou, R. Domingo, Joseph Adoco, D. Zannou, D. Houinato\",\"doi\":\"10.4236/wjns.2019.94021\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Headache disorders are common in HIV-infected patients. These disorders are either primary or secondary. Objective: Determine prevalence and factors associated with primary headache disorders in HIV+ patients. Method: It was a cross-sectional, descriptive and analytical study conducted from 2nd May 2017 to 2nd August 2017 which included HIV+ patients aged 18 years and above. Diagnosis of primary headache disorders was carried out by a Neurologist on the basis of ICHD-II diagnostic criteria. The dependent variable was primary headache disorders. Epi Info Version 7.2.1.0 and STATA11 were used for data analysis. P Results: Primary headache disorders prevalence was 25.2% (124/493).Tension-type headache represented 77.41%. HIV+ patients were aged 42.63 ± 10.14 years. Sex-ratio was estimated at 0.14. Factors associated with primary headache disorders in HIV+ patients were: male (0.36 [0.17 - 0.77]; P = 0.008), Dendi ethnicity (14.8 [2.08 - 101.99]; P = 0.007), trader (3.09 [01.25 - 7.62]; P = 0.02), WHO clinical stage (3.20 [1.43 - 7.17]; P = 0.005), screening duration (1.01 [1.00 - 1.01]; P = 0.00), hypertension (10.28 [4.44 - 23.83]; P ≤ 0.001). Conclusion: This study helped to determine the standard profile of HIV+ patient with primary headache disorders. It will contribute to save costs associated with paraclinical examinations, while in search of secondary etiologies within an African context with limited financial resources.\",\"PeriodicalId\":23878,\"journal\":{\"name\":\"World Journal of Neuroscience\",\"volume\":\"8 3 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"World Journal of Neuroscience\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4236/wjns.2019.94021\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Neuroscience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4236/wjns.2019.94021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Primary Headache Disorders in HIV-Infected Patients within a Hospital Setting in Sub-Saharan Africa, Benin Case: Prevalence and Associated Factors
Introduction: Headache disorders are common in HIV-infected patients. These disorders are either primary or secondary. Objective: Determine prevalence and factors associated with primary headache disorders in HIV+ patients. Method: It was a cross-sectional, descriptive and analytical study conducted from 2nd May 2017 to 2nd August 2017 which included HIV+ patients aged 18 years and above. Diagnosis of primary headache disorders was carried out by a Neurologist on the basis of ICHD-II diagnostic criteria. The dependent variable was primary headache disorders. Epi Info Version 7.2.1.0 and STATA11 were used for data analysis. P Results: Primary headache disorders prevalence was 25.2% (124/493).Tension-type headache represented 77.41%. HIV+ patients were aged 42.63 ± 10.14 years. Sex-ratio was estimated at 0.14. Factors associated with primary headache disorders in HIV+ patients were: male (0.36 [0.17 - 0.77]; P = 0.008), Dendi ethnicity (14.8 [2.08 - 101.99]; P = 0.007), trader (3.09 [01.25 - 7.62]; P = 0.02), WHO clinical stage (3.20 [1.43 - 7.17]; P = 0.005), screening duration (1.01 [1.00 - 1.01]; P = 0.00), hypertension (10.28 [4.44 - 23.83]; P ≤ 0.001). Conclusion: This study helped to determine the standard profile of HIV+ patient with primary headache disorders. It will contribute to save costs associated with paraclinical examinations, while in search of secondary etiologies within an African context with limited financial resources.